PET using new agent is better for CAD diagnosis than SPECT:

06/10/2010 | HealthImaging.com

PET using the experimental agent BMS747158 yielded better images than technetium-99m sestamibi SPECT in the diagnosis of coronary artery disease, a Phase II study showed. The PET method also pinpointed a bigger perfusion defect area than identified by SPECT imaging, according to the study.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI